A breakthrough in CAR-T therapy may allow cancer treatment with a single injection, cutting costs and making care more available.

Researchers have engineered a dual-targeting nanocarrier that safely sneaks potent chemotherapy past the blood-brain barrier. By homing in on a specific protein expressed by both the glioblastoma ...

Scientists are reprogramming the immune system through cutting-edge approaches like CAR-T cells, engineered dendritic vaccines, AI-driven antibody design, and senolytic therapies, highlighting both ...

Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...

Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with precision biologics, announces today the appointment of Thaminda Ramanayake as its new Chief Executive Officer ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...

Head and neck cancer remains a major global health challenge, ranking among the six most common cancers worldwide and claiming hundreds of thousands of lives each year. A growing body of evidence now ...

According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning ...

Digestive tract tumors are malignant diseases characterized by high aggressiveness, heterogeneity and metabolic abnormalities ...